Astrazeneca plc Receivables

Astrazeneca plc (AZN) currently reports a receivables of $15B as of December 2025. In the prior-year period, the figure was $0. Use the charts on this page to explore Astrazeneca plc's receivables history and peer comparisons.

Astrazeneca plc's receivables changed from $0 to $15B (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Astrazeneca plc reported $15B in receivables as of December 2025. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $15B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Astrazeneca plc, and consider following AZN for alerts when major investors trade the stock.

Astrazeneca plc is classified in the Healthcare sector. On receivables, it currently shows $15B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AZN with unrelated industries.